Campaign India Team
Mar 14, 2022

Piramal Pharma gets Ajay Devgn as its brand ambassador for Tetmosol

Aims to expand its offerings in the skin infection category

Piramal Pharma gets Ajay Devgn as its brand ambassador for Tetmosol

Piramal Pharma’s consumer products division has announced the appointment of actor Ajay Devgn as brand ambassador for its flagship brand, Tetmosol. 

 

With this association, Devgn will be responsible for promoting Testmosol to consumers pan India and aims to enhance its consumer market reach. 

 

The brand aims to expand its offerings in the skin infection category with Tetmosol Dusting Powder and Tetmosol Plus Cream. 

 

Nitish Bajaj, CEO, Piramal Pharma, consumer products division, said, “As we enter the next phase of growth, we are excited to work with Ajay Devgn to promote Tetmosol to our consumers across India and enhance our reach. Owing to the tropical climate, India has a high incidence of skin infections, and therefore we have introduced two new product offerings: Tetmosol Dusting Powder and Tetmosol Plus Cream. Ajay Devgn has established himself as one of India's most popular actors with his fierce performances and resonates very well with our decades-old brand.” 

 

 

Source:
Campaign India

Related Articles

Just Published

3 hours ago

Not every Cannes Lion roars in real life

Amid Cannes backlash, a creative reckoning unfolds. Famous Innovations’ founder and chief creative officer wonders, where do bold ideas end and brand accountability begin in awards season?

5 hours ago

Cannes Lions tightens reins as AI blurs boundaries

After revoked wins and synthetic scandals, Cannes Lions introduces new integrity rules to verify claims and rein in AI misuse.

5 hours ago

Cultural ‘Tadka’ drives India’s most effective ads ...

Kantar’s Creative Effectiveness Awards show that when brands serve emotion with local flavour, consumers don’t just notice—they respond.

1 day ago

WPP has appointed Cindy Rose, a senior Microsoft ...

She is already a WPP non-executive director on its board.